March was not a failure of gold’s role, but a reminder of how markets function under stress. Liquidity, not fundamentals, ...

Trevi Therapeutics shifts to late-stage biotech with Haduvio for IPF chronic cough. Click here to read my latest analysis of ...

Definium Therapeutics, Inc. rated Strong Buy: 2026 phase 3 DT120 data and DT402 ASD readout, strong cash runway and catalysts ...

As the conflict in Iran started, retail trading has fallen significantly. Retail saw reduced ETF activity, down ~$5 bn/day.

Yesterday’s TSMC earnings call was yet another confirmation that the AI momentum right now is a one-way street: up and to the ...

Good morning, everyone, and welcome to our Q1 '26 trading update. I'm Walter Hess, the CEO, and I'm joined today by our CFO, Daniel Wuest. In line with what we announced at the full year conference, ...

ChargePoint Holdings, Inc. is upgraded to Buy after a 76% correction, with recent insider buying and signs of a bottoming ...

The S&P 500 (SPY) surged 11% since late March, but I believe the rally is overextended and ripe for a pullback.

Corporate workers in America have faced the brunt of job cuts since the start of the year. If 2025 was a year of ...

Crude oil plunges as Strait of Hormuz stays open; see top 10 oil stocks by Seeking Alpha Quant Ratings (XOM, CVX, VLO) and ...

Q1 2026 earnings call recap: sales growth, Asia outperformance, unchanged 2026 margin/cash flow guidance, and key tariff/raw ...

Microsoft Corporation is downgraded to hold as Azure/M365 growth slows, AI competition rises, and capex threatens margins & ...